Skip to content

BWINDI

Active
Private limited company·Activiteiten van medisch specialisten· 2 yrs active
Rijsenbergstraat 34 ·9000 Gent, Belgium
KBO/BCE: BE 0804.870.168
Watch Print / PDF
Full dossier in preparation

Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.

Process with priority Sign in free to move this company to the front.
Age2 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of BWINDI is 0.1% (very low). The 2025 annual accounts show equity of €80k and a net result of €36k. Equity is growing by ~80.8% per year across the filed fiscal years. Its solvency ranks better than 95% of 2210 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.

Signals

3 signals · with evidence
Strong solvency vs sector
Solvency is in the sector's strongest quartile: better than 95% of 2210 peers (2025). A comfortable equity buffer.
View the sector comparison
Consistently profitable
Positive net result in the two most recent financial years (2024 and 2025).
View the result trend
Growing equity
Equity grew over 2023-2025. Profits are largely retained rather than distributed.
View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-01-2026, 183 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 3 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 29-01-2026 183 d early 2026-00017569
31-12-2024 31-07-2025 06-06-2025 55 d early 2025-00122406
31-12-2023 31-07-2024 17-06-2024 44 d early 2024-00132373

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
Young company
Founded in 2023, under 3 years, statistically higher risk.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.1% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Annual accounts: healthy financial profile

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€36k-1.7%
Working capital€76k+95.2%

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 29-01-2026 with the NBB · fiscal year 2025 · micro
€0€20k€40kOperating result 2023: €9k€9kNet result 2023: €7k€7kOperating result 2024: €46k€46kNet result 2024: €36k€36kOperating result 2025: €45k€45kNet result 2025: €36k€36k202320242025
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~80.8%/year over 3 fiscal years, indicative, assuming unchanged policy.
€0€50k€100k€150k€200k2026: €115k (€109k - €122k)2027: €151k (€145k - €158k)2028: €187k (€180k - €193k)2023: €9k2024: €44k2025: €80k202320242025202620272028
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 97.7% 58.1%
better than 95% of 2210 sector peers
Net result €36k €60k
better than 34% of 2208 sector peers
Equity €80k €74k
better than 52% of 2210 sector peers
Gross operating margin €46k €96k
better than 25% of 2210 sector peers
Total assets €82k €186k
better than 20% of 2210 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P95
2023: P84 · n=53302024: P89 · n=65742025: P95 · n=22102023 2025
Stable position over 2023-2025 · n=2210-6574
Net result P34
2023: P18 · n=53292024: P43 · n=65682025: P34 · n=22082023 2025
Improving position over 2023-2025 · n=2208-6568
Equity P52
2023: P13 · n=53322024: P33 · n=65742025: P52 · n=22102023 2025
Improving position over 2023-2025 · n=2210-6574
Gross operating margin P25
2023: P10 · n=53262024: P32 · n=65762025: P25 · n=22102023 2025
Improving position over 2023-2025 · n=2210-6576
Describes the position versus peers, not a forecast.
EBITDA
€46k
-0.8% 23-25
Net profit
€36k
-1.7% 23-25
Cash flow
€37k
+0.5% 23-25
Total assets
€82k
+69.9% 23-25
Equity
€80k
+81.0% 23-25
Working capital
€76k
+95.2% 23-25
Income taxes
€9k
+1.3% 23-25
Dividends
€0
-100.0% 23-25
Debt
€2k
-52.3% 23-25
Debt ≤ 1y
€2k
-52.3% 23-25
Current ratio
40.54
+280.0% 23-25
Quick ratio
40.54
+280.0% 23-25
Solvency
97.7%
+6.5% 23-25
Debt / equity
0.02
-73.6% 23-25
ROE
44.8%
-45.7% 23-25
ROA
43.7%
-42.2% 23-25
Interest coverage
296.85
-9.9% 23-25
Figures by fiscal year
Fiscal year2025
Depositmicro
Revenue-
EBITDA€46k
Net profit€36k
Cash flow€37k
Staff costs-
Income taxes€9k
Dividends€0
Total assets€82k
Equity€80k
Debt€2k
of which ≤ 1y€2k
of which > 1y-
Working capital€76k
Employees (FTE)-
Ratios (computed)
2025
Current ratio40.54
Quick ratio40.54
Working capital ratio92.5%
Solvency97.7%
Debt / equity0.02
Long-term debt ratio-
Interest coverage296.85
Gross margin-
Net margin-
ROA43.7%
ROE44.8%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€82k
Fixed assets 21/28€4k
Tangible fixed assets 22/27€4k
Current assets 29/58€78k
Investments 50/53€0
Cash & bank 54/58€67k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€82k
Equity 10/15€80k
Contributions / capital 10/11€3k
Accumulated profits (losses) 14€77k
Amounts payable 17/49€2k
Amounts payable within one year 42/48€2k
Trade debts payable within one year 44€1k
Income statement
Gross operating margin 9900€46k
Operating result 9901€45k
Financial income 75€658
Financial charges 65€154
Result before taxes 9903€45k
Income taxes 67/77€9k
Net result for the period 9904€36k
Result to be appropriated 9905€36k
You're seeing the latest fiscal year only. Unlock 2 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
93 / 100 Excellent
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

on the map · from the address register
exact location from the address register On OpenStreetMap

Establishment units

1 location
Dr. Astrid Dejonckheere, kinder- en jeugdpsychiater
Rijsenbergstraat 34, 9000 GentActiviteiten van medisch specialisten
since 20232.349.966.441
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area132 m²
Buildings1
Building footprint80 m²
Volume (LiDAR)681 m³
Tallest building10.5 m · ±3 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44809I0250/00E002 Flanders 132 m² 1 · 80 m² 10.5 m · 3 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

1 acts
All acts · 1 updated 1 year ago
2025
19-03-2025 Articles of association amended, translation of the articles, coordination of the articles and amendment of specific articles Statutes amendment·Marc Claeys
Summary: De vennootschap heeft tot voorwerp de uitoefening van de geneeskunde, meer bepaald de psychiatrie, door haar arts-vennoot, met uitsluiting van alle handelsobjectieven en rekening houdende met de wette…Notary: Marc Claeys · Gent

Analysis

Snowflake analysis

financial profile on 5 axes
Health93Profitability100Solvency100Growth78Stability82
91 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 93
Profitability 100
Solvency 100
Growth 78
Stability 82

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Praktijken van specialisten86220Activiteiten van medisch specialisten86220
Primary activity highlighted.
Names & trade names
Legal nameNL BWINDI
Registered office
Rijsenbergstraat 34
9000 Gent, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.